JP2007512377A5 - - Google Patents

Download PDF

Info

Publication number
JP2007512377A5
JP2007512377A5 JP2006541731A JP2006541731A JP2007512377A5 JP 2007512377 A5 JP2007512377 A5 JP 2007512377A5 JP 2006541731 A JP2006541731 A JP 2006541731A JP 2006541731 A JP2006541731 A JP 2006541731A JP 2007512377 A5 JP2007512377 A5 JP 2007512377A5
Authority
JP
Japan
Prior art keywords
composition
matrix
vector
expression cassette
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006541731A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007512377A (ja
JP4842139B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/039633 external-priority patent/WO2005051971A1/en
Publication of JP2007512377A publication Critical patent/JP2007512377A/ja
Publication of JP2007512377A5 publication Critical patent/JP2007512377A5/ja
Application granted granted Critical
Publication of JP4842139B2 publication Critical patent/JP4842139B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006541731A 2003-11-24 2004-11-23 皮膚瘢痕の縮小 Expired - Fee Related JP4842139B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US52499303P 2003-11-24 2003-11-24
US60/524,993 2003-11-24
PCT/US2004/039633 WO2005051971A1 (en) 2003-11-24 2004-11-23 Reduction of dermal scarring

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011160099A Division JP2011207912A (ja) 2003-11-24 2011-07-21 皮膚瘢痕の縮小

Publications (3)

Publication Number Publication Date
JP2007512377A JP2007512377A (ja) 2007-05-17
JP2007512377A5 true JP2007512377A5 (enExample) 2007-12-27
JP4842139B2 JP4842139B2 (ja) 2011-12-21

Family

ID=34632948

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006541731A Expired - Fee Related JP4842139B2 (ja) 2003-11-24 2004-11-23 皮膚瘢痕の縮小
JP2011160099A Withdrawn JP2011207912A (ja) 2003-11-24 2011-07-21 皮膚瘢痕の縮小

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011160099A Withdrawn JP2011207912A (ja) 2003-11-24 2011-07-21 皮膚瘢痕の縮小

Country Status (13)

Country Link
US (3) US7465442B2 (enExample)
EP (1) EP1692154A4 (enExample)
JP (2) JP4842139B2 (enExample)
KR (1) KR101167330B1 (enExample)
CN (2) CN100482674C (enExample)
AU (1) AU2004293474B2 (enExample)
BR (1) BRPI0416920A (enExample)
CA (1) CA2546287C (enExample)
IL (1) IL175603A (enExample)
NO (1) NO20062978L (enExample)
NZ (1) NZ546983A (enExample)
WO (1) WO2005051971A1 (enExample)
ZA (1) ZA200604147B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100482674C (zh) * 2003-11-24 2009-04-29 坎吉有限公司 皮肤瘢痕形成的减少
AU2009205429A1 (en) 2008-01-14 2009-07-23 Conventus Orthopaedics Inc. Apparatus and methods for fracture repair
US8796443B2 (en) 2008-09-22 2014-08-05 Rxi Pharmaceuticals Corporation Reduced size self-delivering RNAi compounds
EP2523614A4 (en) 2010-01-15 2017-02-15 Conventus Orthopaedics, Inc. Rotary-rigid orthopaedic rod
CN105534561B (zh) 2010-01-20 2018-04-03 康文图斯整形外科公司 用于骨接近和骨腔准备的装置及方法
JP2013521880A (ja) 2010-03-08 2013-06-13 コンベンタス オーソピディックス, インコーポレイテッド 骨インプラントを固定するための装置および方法
KR20180044433A (ko) 2010-03-24 2018-05-02 알엑스아이 파마슈티칼스 코포레이션 진피 및 섬유증성 적응증에서의 rna 간섭
EP3077050B1 (en) * 2013-12-04 2020-10-21 Phio Pharmaceuticals Corp. Methods for treatment of wound healing utilizing chemically modified oligonucleotides
AU2014362251B2 (en) 2013-12-12 2019-10-10 Conventus Orthopaedics, Inc. Tissue displacement tools and methods
US10900039B2 (en) 2014-09-05 2021-01-26 Phio Pharmaceuticals Corp. Methods for treating aging and skin disorders using nucleic acids targeting Tyr or MMP1
SG11201808704YA (en) 2016-04-14 2018-11-29 Trizell Ltd Viral vector stabilization
WO2019010252A2 (en) 2017-07-04 2019-01-10 Conventus Orthopaedics, Inc. Apparatus and methods for treatment of a bone

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4394370A (en) 1981-09-21 1983-07-19 Jefferies Steven R Bone graft material for osseous defects and method of making same
US4505266A (en) 1981-10-26 1985-03-19 Massachusetts Institute Of Technology Method of using a fibrous lattice
US4485097A (en) 1982-05-26 1984-11-27 Massachusetts Institute Of Technology Bone-equivalent and method for preparation thereof
JPH0662679B2 (ja) 1985-06-21 1994-08-17 新田ゼラチン株式会社 組織親和性コラ−ゲンとその製法
WO1992002247A1 (en) * 1990-08-01 1992-02-20 Chiron Ophthalmics, Inc. Method for treating corneal endothelial wounds
US5302706A (en) 1991-12-16 1994-04-12 Baylor College Of Medicine Senescent cell derived inhibitors of DNA synthesis
US6372249B1 (en) 1991-12-16 2002-04-16 Baylor College Of Medicine Senscent cell-derived inhibitors of DNA synthesis
US5596079A (en) 1991-12-16 1997-01-21 Smith; James R. Mimetics of senescent cell derived inhibitors of DNA synthesis
KR100331363B1 (ko) 1992-10-16 2002-12-05 콜드 스프링 하버 래보레이토리 사이클린복합체재배열및그것과관련된용도
US6211334B1 (en) 1992-10-16 2001-04-03 Cold Spring Harbor Cell-cycle regulatory proteins, and uses related thereto
FR2702152B1 (fr) 1993-03-03 1995-05-24 Inst Nat Sante Rech Med Virus recombinants et leur utilisation en thérapie génique.
CA2170641C (en) 1993-08-30 2011-11-15 James R. Smith Senescent cell-derived inhibitors of dna synthesis
TW442569B (en) 1993-10-25 2001-06-23 Canji Inc Recombinant adenoviral vector
US6210939B1 (en) 1993-10-25 2001-04-03 Canji, Inc. Recombinant adenoviral vector and methods of use
EP0702730A4 (en) 1994-03-18 1997-05-07 Univ Utah Res Found COREWAY MUTTATIONS IN THE MTS GENE AND METHODS FOR DETECTING AN APPROXIMATION OF CANCER IN THE MTS GENE
ATE283355T1 (de) 1994-05-24 2004-12-15 Baylor College Medicine Mimetika von aus alternden zellen abgeleitete hemmer der dna synthese
US5851806A (en) * 1994-06-10 1998-12-22 Genvec, Inc. Complementary adenoviral systems and cell lines
US5631156A (en) 1994-06-21 1997-05-20 The University Of Michigan DNA encoding and 18 KD CDK6 inhibiting protein
WO1996012506A1 (en) 1994-10-24 1996-05-02 Baylor College Of Medecine Senescent cell-derived inhibitors of dna synthesis
US5827702A (en) 1994-10-31 1998-10-27 Genentech, Inc. Ocular gene therapy
GB9422175D0 (en) 1994-11-03 1994-12-21 Univ Dundee Indentification of the p21 waf1-pcna interaction site and therapeutic applications thereof
AU4602396A (en) 1994-12-22 1996-07-10 Regents Of The University Of Michigan, The Dna encoding a 20 kd cdk6 inhibiting protein
US5837520A (en) 1995-03-07 1998-11-17 Canji, Inc. Method of purification of viral vectors
US5856094A (en) 1995-05-12 1999-01-05 The Johns Hopkins University School Of Medicine Method of detection of neoplastic cells
US6027742A (en) 1995-05-19 2000-02-22 Etex Corporation Bioresorbable ceramic composites
US5756283A (en) 1995-06-05 1998-05-26 The Trustees Of The University Of Pennsylvania Method for improved production of recombinant adeno-associated viruses for gene therapy
HUP9901908A3 (en) 1995-07-17 2000-02-28 Univ Texas P16 expression constructs and their application in cancer therapy
GB9519275D0 (en) 1995-09-21 1995-11-22 Univ Dundee Substances and their therapeutic use
US5863904A (en) 1995-09-26 1999-01-26 The University Of Michigan Methods for treating cancers and restenosis with P21
US5837511A (en) * 1995-10-02 1998-11-17 Cornell Research Foundation, Inc. Non-group C adenoviral vectors
US6001853A (en) * 1996-01-26 1999-12-14 The United States Of America As Represented By The Department Of Health And Human Services Hydroxylamine compositions for the prevention or retardation of cataracts
AU726584B2 (en) 1996-04-10 2000-11-09 University Of Southern California Gene therapy for proliferative vitreoretinopathy
IT1285790B1 (it) * 1996-09-24 1998-06-24 Angeletti P Ist Richerche Bio Adenovirus difettivi ricombinanti che codificano per mutanti di interleuchina 6 umana (hil-6) con attivita' antagonista o
US6274614B1 (en) 1997-02-11 2001-08-14 Qlt Inc. Methods, compositions and articles for reducing or preventing the effects of inflammation
JPH11205102A (ja) 1998-01-13 1999-07-30 Mitsubishi Electric Corp 遅延同期回路
US6489305B1 (en) 1998-05-08 2002-12-03 Canji, Inc. Methods and compositions for the treatment of ocular diseases
US6395029B1 (en) * 1999-01-19 2002-05-28 The Children's Hospital Of Philadelphia Sustained delivery of polyionic bioactive agents
AU6919300A (en) * 1999-08-20 2001-03-19 University Of Pittsburgh Methods for in vivo gene delivery to sites of cartilage damage
US6579522B1 (en) * 2000-06-27 2003-06-17 Genvec, Inc. Replication deficient adenoviral TNF vector
US6667173B2 (en) 2000-12-01 2003-12-23 The Schepens Eye Research Institute Nucleic acids encoding platelet derived growth factor-alpha receptors
CN100482674C (zh) * 2003-11-24 2009-04-29 坎吉有限公司 皮肤瘢痕形成的减少
US7947267B2 (en) * 2004-10-08 2011-05-24 Potentia Pharmaceuticals, Inc. Viral complement control proteins for eye disorders

Similar Documents

Publication Publication Date Title
Pang et al. An overview of the therapeutic potential of regenerative medicine in cutaneous wound healing
JP2007512377A5 (enExample)
US7183381B2 (en) Composition of lactoferrin related peptides and uses thereof
JP7033109B2 (ja) 創傷治癒の方法
Ziesche et al. A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis
CN104884076B (zh) 利用了hmgb1片段的心肌梗塞的治疗方法
CN1137723C (zh) 强化的用于加速伤口愈合的伤口覆盖物和组合物
EP2234628B1 (en) Compositions and methods of promoting wound healing
HRP20090597T1 (hr) Muteini čimbenika rasta fibroblasta 21
JP2024123220A5 (enExample)
JP2006516571A5 (enExample)
JP2005506275A5 (enExample)
Yang et al. Antioxidant-enriched autologous biogel promoted diabetic wound healing by remodeling inherent posttraumatic inflammatory patterning and restoring compromised microenvironment homeostasis
JP2015528479A5 (enExample)
Zhang et al. A multiple-crosslinked injectable hydrogel for modulating tissue microenvironment and accelerating infected diabetic wound repair
EP1169052A2 (en) Angiogenic growth factors for treatment of peripheral neuropathy
JP2006296896A (ja) コラーゲン薄膜シート、その製造方法、それを用いた再建方法、および自己組織再生誘導型人工皮膚・粘膜
MXPA05004074A (es) Nuevos adenovirus, acidos nucleicos que los codifican y su uso.
CN109793913A (zh) 包含表皮生长因子的缓释膜敷料
JP2009517343A5 (enExample)
Ghofrani et al. Collagen-Based Therapies for Accelerated Wound Healing
CN114984233B (zh) 一种基于鲵皮肤分泌物的局部给药系统及其应用
JP2014501242A5 (enExample)
Qin et al. Bionic Microneedle Patch Inspired by Drosophila Tarsal Paws Boosts Healing in Bacterial Infectious Stomatitis
JP2008511652A5 (enExample)